Patients who are uninsured, may be eligible to receive VEGZELMA® (bevacizumab-adcd) at no cost. Patient eligibiliy criteria, including household income limits, and program
terms and conditions apply*. Celltrion CONNECT can help evaluate patients’ eligibility for assistance.
To enroll in PAP,
download and fax the PAP enrollment application to
614-633-2259.
